Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of 3.45 is 19% below its 5-year average of 4.25, near the low end of its 5-year range (3.04–4.90).
22.73% below its 12-month average of 4.46.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): 1.24.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 18 comparable quarters.
FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters Quote observation: 2026-09-26T00:15:46.996Z. Historical observations retain their original dates. Historical series through 2026-09-11.
EARNINGS PER SHARE (EPS)
3.45
EARNINGS PER SHARE (EPS) AVG TTM
4.46
EARNINGS PER SHARE (EPS) AVG 3Y
4.05
EARNINGS PER SHARE (EPS) AVG 5Y
4.25
EARNINGS PER SHARE (EPS) AVG 10Y
N/A
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
-22.73%
CURRENT VS 3Y AVG
-14.76%
CURRENT VS 5Y AVG
-18.82%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
GE HealthCare Technologies Inc.
Market Cap
$30.10B
Earnings Per Share (EPS)
3.45
TTM Avg
4.46
3Y Avg
4.05
5Y Avg
4.25
Market Cap
$30.53B
Earnings Per Share (EPS)
-10.44
TTM Avg
-3.64
3Y Avg
-0.05
5Y Avg
0.88
Market Cap
$30.55B
Earnings Per Share (EPS)
44.49
TTM Avg
41.42
3Y Avg
39.43
5Y Avg
36.04
Market Cap
$33.63B
Earnings Per Share (EPS)
5.65
TTM Avg
10.02
3Y Avg
12.26
5Y Avg
14.06
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| GE HealthCare Technologies Inc. (GEHC) | $30.10B | 3.45 | 4.46 | 4.05 | 4.25 |
| Zoetis Inc. (ZTS)vs › | $29.79B | 6.07 | 5.75 | 5.27 | 4.80 |
| Centene Corp. (CNC)vs › | $30.53B | -10.44 | -3.64 | -0.05 | 0.88 |
| Mettler-Toledo International Inc. (MTD)vs › | $30.55B | 44.49 | 41.42 | 39.43 | 36.04 |
| Medline Inc. (MDLN)vs › | $29.34B | 0.86 | 1.48 | 0.80 | 0.80 |
| Alcon Inc. (ALC)vs › | $31.44B | 1.30 | 2.02 | 1.68 | 1.07 |
| ResMed Inc. (RMD)vs › | $32.20B | 10.40 | 10.00 | 8.26 | 6.94 |
| DexCom, Inc. (DXCM)vs › | $32.69B | 2.53 | 1.80 | 1.48 | 1.30 |
| Biogen Inc. (BIIB)vs › | $33.63B | 5.65 | 10.02 | 12.26 | 14.06 |
| Quest Diagnostics Incorporated (DGX)vs › | $26.08B | 9.42 | 8.33 | 8.09 | 9.83 |
Trailing EPS (TTM)
$3.45
Forward EPS (Est.)
$4.93
P/E Ratio
19.3
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | 4.56 |
| 2024-12-31 | 4.37 |
| 2023-12-31 | 3.04 |
| 2022-12-31 | 4.22 |
| 2021-12-31 | 4.90 |
| 2020-12-31 | 4.41 |
| 2019-12-31 | 3.35 |
